Satsuma Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.25
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.54
|
-0.48
|
0.06
|
11.11%
|
|
2022-06-30
|
-0.49
|
-0.52
|
-0.03
|
-6.12%
|
|
2022-03-31
|
-0.49
|
-0.49
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.48
|
-0.49
|
-0.01
|
-2.08%
|
|
2021-09-30
|
-0.51
|
-0.42
|
0.09
|
17.65%
|
|
2021-06-30
|
-0.41
|
-0.38
|
0.03
|
7.32%
|
|
2021-03-31
|
-0.42
|
-0.48
|
-0.06
|
-14.29%
|
|
2020-12-31
|
-0.53
|
-0.72
|
-0.19
|
-35.85%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.49
|
|
2021-12-31
|
-1.77
|
|
2020-12-31
|
-2.74
|
|
2019-12-31
|
-3.34
|